ThailandResearch and clinical trials
Ablation reduced dangerous rhythm episodes in Brugada syndrome
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In Thailand, a trial was carried out in patients with Brugada syndrome who had an implanted shock device (defibrillator). Fifty-two patients were randomly divided into two groups. One group had ablation on the outer surface of the heart. Over three years, dangerous rhythm episodes were clearly fewer in this group. Most of those who had ablation remained free of episodes after a single procedure.
What does it mean for patients and families?
This is a small but randomized study. All patients in the study had a shock device. A heart rhythm specialist decides whether this procedure is suitable for you.
Source
Scientific paper: Brugada Syndrome Ablation for the Prevention of Ventricular Fibrillation Episodes (BRAVE). Heart Rhythm, 2025. DOI: 10.1016/j.hrthm.2025.04.033 · PubMed 40294736
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Brugada syndrome
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.